Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CT/New Haven
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in New Haven, CT

Studies commonly pay $75 to $4,500 per completed study

1,178 clinical trials are currently recruiting participants within 30 miles of New Haven. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,178studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near New Haven right now

Top 25 of 1,178 recruiting studies, sorted by proximity — each links to its official registry page

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Saint Vincent's Medical Center (SVMC) — Bridgeport, Connecticut (16.5 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Yale University — New Haven, Connecticut (0.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Integrated Treatment for Enhancing Growth in Recovery During Adolescence

Alcohol Use Disorder, Cannabis Use Disorder N/A Interventional 294 participants sought
UConn Health — Farmington, Connecticut (28.6 mi) · Sponsor: Massachusetts General Hospital
See eligibility & contact on ClinicalTrials.gov (NCT06395467)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
PACT Kidney Care — Orange, Connecticut (5.7 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Yale University School of Medicine — New Haven, Connecticut (0.3 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas

Gastroesophageal Adenocarcinoma Phase 2 Interventional 242 participants sought
Yale University — New Haven, Connecticut (0.3 mi) · Sponsor: American Association for Cancer Research
See eligibility & contact on ClinicalTrials.gov (NCT07290985)

Fear and Anxiety in Anesthesia-Naïve Patients Pre-operatively vs Post-operatively

Anxiety, Anesthesia Awareness N/A Observational 40 participants sought
Stony Brook University Hospital — Stony Brook, New York (28.9 mi) · Sponsor: Stony Brook University
See eligibility & contact on ClinicalTrials.gov (NCT07559461)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Smilow Cancer Center/Yale-New Haven Hospital — New Haven, Connecticut (0.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Advanced Prostate Cancer, Metastatic Prostate Cancer Phase 1 Interventional 210 participants sought
Yale Cancer Center — New Haven, Connecticut (0.3 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05800665)

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1 Interventional 604 participants sought
Smilow Cancer Hospital (Yale University) — New Haven, Connecticut (0.3 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06040541)

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) N/A Observational 30 participants sought
Yale School Of Medicine — New Haven, Connecticut (0.3 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT06538064)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Yale-New Haven Hospital-Yale Cancer Center — New Haven, Connecticut (0.3 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Yale-New Haven Hospital — New Haven, Connecticut (0.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

Advanced Solid Tumor Phase 1 Interventional 105 participants sought
Yale Cancer Center — New Haven, Connecticut (0.3 mi) · Sponsor: BeOne Medicines
See eligibility & contact on ClinicalTrials.gov (NCT07226349)

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Solid Tumors, Sarcomas Phase 1 Interventional 180 participants sought
Zai Lab Site 02030 — New Haven, Connecticut (0.3 mi) · Sponsor: Zai Lab (Shanghai) Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07374848)

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

Clostridium Difficile Infection Recurrence Phase 2 Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (6.0 mi) · Sponsor: Acurx Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07513285)

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
Veterans Affairs Connecticut Healthcare System-West Haven Campus — West Haven, Connecticut (3.0 mi) · Sponsor: Canadian Cancer Trials Group
See eligibility & contact on ClinicalTrials.gov (NCT06592924)

A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

EGFR Inhibitor-associated Rash Phase 1, Phase 2 Interventional 32 participants sought
Yale University School of Medicine — New Haven, Connecticut (0.3 mi) · Sponsor: Azitra Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06830863)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — New Haven, Connecticut (0.3 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Bridgeport Hospital — Bridgeport, Connecticut (16.5 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
Yale University School of Medicine — New Haven, Connecticut (0.3 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07007312)

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) Phase 2 Interventional 40 participants sought
Uconn Health — Farmington, Connecticut (28.6 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07213973)
Actively enrolling

Studies you may be able to join near New Haven

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in New Haven

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Yale Center for Clinical Investigation

2 Church St S #401, New Haven, CT 06519
(203) 785-3482

Pfizer New Haven Clinical Research Unit

★ 4.2
1 Howe St, New Haven, CT 06511
(800) 254-6398
"I had been doing studies here for some years and had a really bad experience with a doctor during screening. I think the dr was racist i don’t know b…"
— aster390, 1★

Center for Outcomes Research and Evaluation

★ 5.0
195 Church St 5th Floor, New Haven, CT 06510
(203) 497-1239

Chase Medical Research, LLC

★ 5.0
1952 Whitney Ave, Hamden, CT 06517
(203) 419-4404
"I would like to start by saying that stuff are amazing there. Special thanks to three very professional and cool at the same time ladies Amanda, Sam…"
— Denise Mizla, 5★

Yale Interventional Oncology Research Lab

333 Cedar St, New Haven, CT 06510

Alzheimer’s Disease Research Unit

★ 5.0
1 Church St, New Haven, CT 06510
(203) 764-8100

MSU Multi-modal Imaging, Neuroinformatics, & Data Science (MINDS) Laboratory

Magnetic Resonance Research Center, 300 Cedar St, New Haven, CT 06519

Yale OCD Research Clinic

34 Park St, New Haven, CT 06510
(203) 974-7523

Medical Research Center of Connecticut

2200 Whitney Avenue Hamden Wallingford, Hamden, CT 06518
(203) 281-5161

Clinical trials in New Haven: what's recruiting

The New Haven area currently has 1,178 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to New Haven, the most active research areas are:

  • Cancer & Oncology13 studies
  • Liver & Kidney1 studies
  • Diabetes & Metabolism1 studies
  • Brain & Mental Health1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from New Haven, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in New Haven

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

New Haven participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in New Haven?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in New Haven safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in New Haven?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of New Haven.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in New Haven typically complete one or two studies per year.

Paid clinical trials near New Haven

Other metros within reach

Waterbury, CT1,134 Bridgeport, CT1,449 Hartford, CT437 Danbury, CT1,160 Norwich, CT115 Springfield, MA315 Yonkers, NY4,161 Queens, NY4,172

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in New Haven Bladder Issues Due To Spinal Cord Injury in New Haven All conditions

More of CT

Bridgeport1,449 Danbury1,160 Waterbury1,134 Hartford437 Norwich115

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts